Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508870
Title A Safety and Pharmacology Study of Atezolizumab (MPDL3280A, Anti-PD-L1 Antibody) Administered Alone or in Combination With Azacitidine in Patients With Myelodysplastic Syndromes
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Stanford University Palo Alto California 94305 United States Details
University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
University of Colorado Hospital - Anschutz Cancer Pavilion Aurora Colorado 80045 United States Details
University of Kansas Medical Center Westwood Kansas 66205 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Nebraska Medical Center; UNMC Oncology/Hematology Omaha Nebraska 68198-7680 United States Details
Montefiore Einstein Cancer Center Bronx New York 10461 United States Details
Roswell Park Cancer Institute; Grace Cancer Drug Center Buffalo New York 14263 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44915 United States Details
Medical University of South Carolina; Hollings Cancer Center Charleston South Carolina 29425 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030-4009 United States Details
University of Virginia Health System; Hematology/Oncology Division Charlottesville Virginia 22908 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field